Antisense Therapeutics: A devastating disease with no cure but hope is on the horizon
Listen to ASX-listed Antisense Therapeutics Managing Director Mark Diamond talk to Matt Birney on the Bulls N’ Bears Report about Antisense’s clever developing drug technology that is slated to tackle a medicinal market expected to be worth US$10b by 2030.